PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
69.20
Similar ESG score to INKT's 68.97. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
70.45
Environmental score 1.1-1.2x INKT's 59.45. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
70.37
Social score 90-95% of INKT's 76.83. Bill Ackman would demand clear social improvement catalysts.
66.79
Governance score 90-95% of INKT's 70.64. Bill Ackman would demand clear governance improvement catalysts.